Borderline Personality Disorder.
Mendez-Miller M, Naccarato J, Radico JA.
Am Fam Physician. 2022 Feb 1;105(2):156-161.
Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R, Kimonis V, Butler MG.
Int J Mol Sci. 2023 Jan 21;24(3):2150. doi: 10.3390/ijms24032150.
Psychosocial impact of COVID-19.
Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ.
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):779-788. doi: 10.1016/j.dsx.2020.05.035. Epub 2020 May 27.
Review of the clinical approach to the treatment of disruptive mood dysregulation disorder.
Hendrickson B, Girma M, Miller L.
Int Rev Psychiatry. 2020 May;32(3):202-211. doi: 10.1080/09540261.2019.1688260. Epub 2019 Nov 28.
Emotional Dysregulation: A Trauma-Informed Approach.
Keeshin BR, Bryant BJ, Gargaro ER.
Child Adolesc Psychiatr Clin N Am. 2021 Apr;30(2):375-387. doi: 10.1016/j.chc.2020.10.007. Epub 2021 Feb 15.
Psychometric Properties of the Emotional Outburst Inventory (EMO-I): Rating What Children Do When They Are Irritable.
Carlson GA, Silver J, Klein DN.
J Clin Psychiatry. 2022 Jan 25;83(2):21m14015. doi: 10.4088/JCP.21m14015.
Smith-Magenis Syndrome.
Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B.
2001 Oct 22 [updated 2022 Mar 10]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
Focus on Disruptive Mood Dysregulation Disorder: A review of the literature.
Bruno A, Celebre L, Torre G, Pandolfo G, Mento C, Cedro C, Zoccali RA, Muscatello MRA.
Psychiatry Res. 2019 Sep;279:323-330. doi: 10.1016/j.psychres.2019.05.043. Epub 2019 Jun 1.
Approach to the Patient With Prader-Willi Syndrome.
Höybye C, Tauber M.
J Clin Endocrinol Metab. 2022 May 17;107(6):1698-1705. doi: 10.1210/clinem/dgac082.
Mood Disorder.
Sekhon S, Gupta V.
2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
